CompaniesCorevigilance

Corevigilance

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (7)
View all

Total Trials

7

As Lead Sponsor

0

As Collaborator

7

Total Enrollment

300

By Phase

PHASE1/PHASE2: 3PHASE2: 1PHASE3: 1

By Status

RECRUITING: 2COMPLETED: 2TERMINATED: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
Today
NCT04620239
NCT06532253
Hover over trial bars to see details

Recent Trials

NCT06532253Collaborator
Long-term Safety Trial with NVDX3
PHASE1/PHASE2Recruiting
15 participants
Started: Aug 22, 2024 · Completed: Mar 31, 2036
NCT05961956Collaborator
Study With NVDX3 for Treatment of Low Grade Degenerative Lumbar Spondylolisthesis
PHASE1/PHASE2Active, not recruiting
5 participants
Started: Oct 12, 2023 · Completed: Nov 15, 2025
NCT05987033Collaborator
Proof-of-concept Study with NVDX3 for Treatment of Distal Radius Fractures.
PHASE1/PHASE2Completed
10 participants
Started: Aug 8, 2023 · Completed: Dec 19, 2024
NCT05276401Collaborator
Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer
PHASE2Terminated
3 participants
Started: Mar 11, 2022 · Completed: Jun 15, 2022
NCT04620239Collaborator
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study
PHASE3Recruiting
100 participants
Started: Mar 22, 2021 · Completed: Jan 25, 2029
View all 7 trials →